WO2026015090A1 - Composition anticancéreuse additive comprenant de la sésamine et de l'hespéridine - Google Patents
Composition anticancéreuse additive comprenant de la sésamine et de l'hespéridineInfo
- Publication number
- WO2026015090A1 WO2026015090A1 PCT/TH2024/050031 TH2024050031W WO2026015090A1 WO 2026015090 A1 WO2026015090 A1 WO 2026015090A1 TH 2024050031 W TH2024050031 W TH 2024050031W WO 2026015090 A1 WO2026015090 A1 WO 2026015090A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cancer
- hesperidin
- sesamin
- composition
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La combinaison de sésamine et d'hespéridine permet une approche thérapeutique prometteuse pour le traitement du cancer due à ses effets additifs, améliorant l'efficacité et réduisant potentiellement les effets secondaires par rapport aux thérapies classiques.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/TH2024/050031 WO2026015090A1 (fr) | 2024-07-11 | 2024-07-11 | Composition anticancéreuse additive comprenant de la sésamine et de l'hespéridine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/TH2024/050031 WO2026015090A1 (fr) | 2024-07-11 | 2024-07-11 | Composition anticancéreuse additive comprenant de la sésamine et de l'hespéridine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2026015090A1 true WO2026015090A1 (fr) | 2026-01-15 |
Family
ID=98387191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/TH2024/050031 Pending WO2026015090A1 (fr) | 2024-07-11 | 2024-07-11 | Composition anticancéreuse additive comprenant de la sésamine et de l'hespéridine |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2026015090A1 (fr) |
-
2024
- 2024-07-11 WO PCT/TH2024/050031 patent/WO2026015090A1/fr active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4312402B2 (ja) | 抗うつ剤、抗更年期障害剤、抗老人性痴呆症剤、抗アルツハイマー剤 | |
| US20180133194A1 (en) | Method of treating inflammation using natural compounds and/or diet | |
| CN104758920A (zh) | 一种基于药食同源的痛风保健品 | |
| JP2004182599A (ja) | 強筋肉剤、抗炎症剤 | |
| EP3638247A2 (fr) | Compositions et méthodes pour améliorer le traitement par chimiothérapie du cancer | |
| KR101100786B1 (ko) | 암에 대한 방사선 치료 증진용 조성물 | |
| US6548531B2 (en) | Method for cancer therapy | |
| CN102028689B (zh) | 一种治疗急性淋巴白血病的复方药物组合物 | |
| AU2002246080A1 (en) | Method for Cancer Therapy | |
| WO2026015090A1 (fr) | Composition anticancéreuse additive comprenant de la sésamine et de l'hespéridine | |
| CN1321696C (zh) | 减轻吲哚－3－甲醇及其衍生物不良反应的药物组合物 | |
| CN111000862B (zh) | 靶向线粒体治疗早期癌症的药物组合物及其应用 | |
| CN111110826A (zh) | 靶向线粒体预防癌症发生的药物组合物及其应用 | |
| JP2005289817A (ja) | 抗癌剤 | |
| JP2014218526A (ja) | 抗炎症剤 | |
| CN104189782A (zh) | 一种抗肿瘤的药物组合物 | |
| CN110693903B (zh) | 一种治疗急性单核细胞白血病的药物及三氧化二砷和双氢青蒿素的应用 | |
| KR20190063536A (ko) | 1-팔미토일-2-리놀레오일-3-아세틸글리세롤을 포함하는 급성 방사선 증후군의 예방 또는 치료용 조성물 | |
| US9913816B2 (en) | Method for applying metformin and sodium butyrate in K-ras mutation cancer treatment | |
| CN111558045A (zh) | 一种治疗肺癌的药物组合物 | |
| CN1237066C (zh) | 降脂抗氧化保健品及其制备方法 | |
| CN110403924A (zh) | 一种治疗皮肤黑色素瘤的药物组合物及其制备方法 | |
| KR102576410B1 (ko) | 바실러스 균주와 5-fu를 유효성분으로 하는 대장암 치료용 약학 조성물 | |
| KR102328367B1 (ko) | 아젤록심 d를 유효성분으로 함유하는 방사선 민감성 증진용 조성물 | |
| Rahm | Possible Integration of Natural Solutions to Support Cancer Patients |